Literature DB >> 2412426

The safety of static-dynamic effort soon after myocardial infarction.

N A Wilke, L M Sheldahl, F E Tristani, C V Hughes, J H Kalbfleisch.   

Abstract

Many activities of daily living require static-dynamic effort. To evaluate the safety of such effort 3 weeks after myocardial infarction, 27 male patients underwent a weight-carrying test requiring 5 minutes of treadmill ambulation with graded weight loads of 10 to 30 pounds. The hemodynamic responses with weight carrying were compared to that of a predischarge graded dynamic exercise test. The peak heart rate was significantly lower (p less than 0.01) with weight carrying, the peak systolic blood pressure did not differ, and the diastolic pressure was significantly higher (P less than 0.01). ST segment depression and angina pectoris occurred less frequently with weight carrying. The type and frequency of ventricular arrhythmias were similar between the two tests. We conclude that many men are capable of performing static-dynamic activity equivalent to carrying up to 30 pounds by 3 weeks after myocardial infarction.

Entities:  

Mesh:

Year:  1985        PMID: 2412426     DOI: 10.1016/0002-8703(85)90072-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

Review 1.  Resistive exercise training in cardiac rehabilitation. An update.

Authors:  D E Verrill; P M Ribisl
Journal:  Sports Med       Date:  1996-05       Impact factor: 11.136

2.  Myocardial work during endurance training and resistance training: a daily comparison, from workout session 1 through completion of cardiac rehabilitation.

Authors:  Jenny Adams; Matthew Hubbard; Tiffany McCullough-Shock; Kay Simms; Dunlei Cheng; Julie Hartman; Danielle Strauss; Valerie Anderson; Anne Lawrence; Emily Malorzo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

Review 3.  Weightlifting training in cardiac patients. Considerations.

Authors:  R S McKelvie; N McCartney
Journal:  Sports Med       Date:  1990-12       Impact factor: 11.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.